Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 234

1.

Detection of Tumor Antigen-Specific T-Cell Responses After Oncolytic Vaccination.

Pol JG, Bridle BW, Lichty BD.

Methods Mol Biol. 2020;2058:191-211. doi: 10.1007/978-1-4939-9794-7_12.

PMID:
31486039
2.

Acyl-CoA-Binding Protein Is a Lipogenic Factor that Triggers Food Intake and Obesity.

Bravo-San Pedro JM, Sica V, Martins I, Pol J, Loos F, Maiuri MC, Durand S, Bossut N, Aprahamian F, Anagnostopoulos G, Niso-Santano M, Aranda F, Ramírez-Pardo I, Lallement J, Denom J, Boedec E, Gorwood P, Ramoz N, Clément K, Pelloux V, Rohia A, Pattou F, Raverdy V, Caiazzo R, Denis RGP, Boya P, Galluzzi L, Madeo F, Migrenne-Li S, Cruciani-Guglielmacci C, Tavernarakis N, López-Otín C, Magnan C, Kroemer G.

Cell Metab. 2019 Aug 9. pii: S1550-4131(19)30383-3. doi: 10.1016/j.cmet.2019.07.010. [Epub ahead of print]

PMID:
31422903
3.

The Molecular Hallmarks of the Serrated Pathway in Colorectal Cancer.

De Palma FDE, D'Argenio V, Pol J, Kroemer G, Maiuri MC, Salvatore F.

Cancers (Basel). 2019 Jul 20;11(7). pii: E1017. doi: 10.3390/cancers11071017. Review.

4.

Response heterogeneity to home-based restorative cognitive rehabilitation in multiple sclerosis: An exploratory study.

Fuchs TA, Ziccardi S, Dwyer MG, Charvet LE, Bartnik A, Campbell R, Escobar J, Hojnacki D, Kolb C, Oship D, Pol J, Shaw MT, Wojcik C, Yasin F, Weinstock-Guttman B, Zivadinov R, Benedict RHB.

Mult Scler Relat Disord. 2019 Jun 22;34:103-111. doi: 10.1016/j.msard.2019.06.026. [Epub ahead of print]

PMID:
31254960
5.

Tumor lysis with LTX-401 creates anticancer immunity.

Xie W, Mondragón L, Mauseth B, Wang Y, Pol J, Lévesque S, Zhou H, Yamazaki T, Eksteen JJ, Zitvogel L, Sveinbjørnsson B, Rekdal Ø, Kepp O, Kroemer G.

Oncoimmunology. 2019 Apr 13;8(7):1594555. doi: 10.1080/2162402X.2019.1594555. eCollection 2019.

PMID:
31143516
6.

Trial watch: dietary interventions for cancer therapy.

Lévesque S, Pol JG, Ferrere G, Galluzzi L, Zitvogel L, Kroemer G.

Oncoimmunology. 2019 Apr 3;8(7):1591878. doi: 10.1080/2162402X.2019.1591878. eCollection 2019. Review.

7.

Balancing traditional activities and cognitive pharmaceutical services by community pharmacists: a work sampling study.

van de Pol J, Koster E, Hövels A, Bouvy M.

Int J Clin Pharm. 2019 Aug;41(4):872-879. doi: 10.1007/s11096-019-00852-0. Epub 2019 May 28.

8.
9.
10.

Author Correction: Crizotinib-induced immunogenic cell death in non-small cell lung cancer.

Liu P, Zhao L, Pol J, Levesque S, Petrazzuolo A, Pfirschke C, Engblom C, Rickelt S, Yamazaki T, Iribarren K, Senovilla L, Bezu L, Vacchelli E, Sica V, Melis A, Martin T, Xia L, Yang H, Li Q, Chen J, Durand S, Aprahamian F, Lefevre D, Broutin S, Paci A, Bongers A, Minard-Colin V, Tartour E, Zitvogel L, Apetoh L, Ma Y, Pittet MJ, Kepp O, Kroemer G.

Nat Commun. 2019 Apr 17;10(1):1883. doi: 10.1038/s41467-019-09838-y.

11.

Lethal Poisoning of Cancer Cells by Respiratory Chain Inhibition plus Dimethyl α-Ketoglutarate.

Sica V, Bravo-San Pedro JM, Izzo V, Pol J, Pierredon S, Enot D, Durand S, Bossut N, Chery A, Souquere S, Pierron G, Vartholomaiou E, Zamzami N, Soussi T, Sauvat A, Mondragón L, Kepp O, Galluzzi L, Martinou JC, Hess-Stumpp H, Ziegelbauer K, Kroemer G, Maiuri MC.

Cell Rep. 2019 Apr 16;27(3):820-834.e9. doi: 10.1016/j.celrep.2019.03.058.

12.

Epithelioid sarcoma of paratesticular region: A case report of an unusual case.

Pol JN, Nisar Z, Phadke MD, Kadkol GA.

Indian J Pathol Microbiol. 2019 Apr-Jun;62(2):306-309. doi: 10.4103/IJPM.IJPM_431_18.

PMID:
30971563
13.

Crizotinib-induced immunogenic cell death in non-small cell lung cancer.

Liu P, Zhao L, Pol J, Levesque S, Petrazzuolo A, Pfirschke C, Engblom C, Rickelt S, Yamazaki T, Iribarren K, Senovilla L, Bezu L, Vacchelli E, Sica V, Melis A, Martin T, Xia L, Yang H, Li Q, Chen J, Durand S, Aprahamian F, Lefevre D, Broutin S, Paci A, Bongers A, Minard-Colin V, Tartour E, Zitvogel L, Apetoh L, Ma Y, Pittet MJ, Kepp O, Kroemer G.

Nat Commun. 2019 Apr 2;10(1):1486. doi: 10.1038/s41467-019-09415-3. Erratum in: Nat Commun. 2019 Apr 17;10(1):1883.

14.

Issue framing in online voting advice applications: The effect of left-wing and right-wing headers on reported attitudes.

Kamoen N, van de Pol J, Krouwel A, de Vreese C, Holleman B.

PLoS One. 2019 Feb 21;14(2):e0212555. doi: 10.1371/journal.pone.0212555. eCollection 2019. Erratum in: PLoS One. 2019 May 9;14(5):e0216969.

15.

Anticancer effects of anti-CD47 immunotherapy in vivo.

Iribarren K, Buque A, Mondragon L, Xie W, Lévesque S, Pol J, Zitvogel L, Kepp O, Kroemer G.

Oncoimmunology. 2018 Dec 11;8(3):1550619. doi: 10.1080/2162402X.2018.1550619. eCollection 2019.

PMID:
30723582
16.

Trait Conscientiousness predicts rate of longitudinal SDMT decline in multiple sclerosis.

Fuchs TA, Wojcik C, Wilding GE, Pol J, Dwyer MG, Weinstock-Guttman B, Zivadinov R, Benedict RH.

Mult Scler. 2019 Jan 7:1352458518820272. doi: 10.1177/1352458518820272. [Epub ahead of print]

PMID:
30615562
17.

Kidney stones and the risk of renal cell carcinoma and upper tract urothelial carcinoma: the Netherlands Cohort Study.

van de Pol JAA, van den Brandt PA, Schouten LJ.

Br J Cancer. 2019 Feb;120(3):368-374. doi: 10.1038/s41416-018-0356-7. Epub 2018 Dec 19.

PMID:
30563989
18.

Human native endocarditis caused by Streptococcus canis-a case report.

Mališová B, Šantavý P, Lovečková Y, Hladký B, Kotásková I, Pol J, Lonský V, Němec P, Freiberger T.

APMIS. 2019 Jan;127(1):41-44. doi: 10.1111/apm.12905.

PMID:
30549135
19.

Preclinical evaluation of a MAGE-A3 vaccination utilizing the oncolytic Maraba virus currently in first-in-human trials.

Pol JG, Acuna SA, Yadollahi B, Tang N, Stephenson KB, Atherton MJ, Hanwell D, El-Warrak A, Goldstein A, Moloo B, Turner PV, Lopez R, LaFrance S, Evelegh C, Denisova G, Parsons R, Millar J, Stoll G, Martin CG, Pomoransky J, Breitbach CJ, Bramson JL, Bell JC, Wan Y, Stojdl DF, Lichty BD, McCart JA.

Oncoimmunology. 2018 Sep 19;8(1):e1512329. doi: 10.1080/2162402X.2018.1512329. eCollection 2019.

20.

Trial watch: Peptide-based vaccines in anticancer therapy.

Bezu L, Kepp O, Cerrato G, Pol J, Fucikova J, Spisek R, Zitvogel L, Kroemer G, Galluzzi L.

Oncoimmunology. 2018 Sep 6;7(12):e1511506. doi: 10.1080/2162402X.2018.1511506. eCollection 2018. Review.

21.

Trial Watch: Oncolytic viro-immunotherapy of hematologic and solid tumors.

Pol JG, Lévesque S, Workenhe ST, Gujar S, Le Boeuf F, Clements DR, Fahrner JE, Fend L, Bell JC, Mossman KL, Fucikova J, Spisek R, Zitvogel L, Kroemer G, Galluzzi L.

Oncoimmunology. 2018 Aug 27;7(12):e1503032. doi: 10.1080/2162402X.2018.1503032. eCollection 2018. Review.

22.

Development and applications of oncolytic Maraba virus vaccines.

Pol JG, Atherton MJ, Bridle BW, Stephenson KB, Le Boeuf F, Hummel JL, Martin CG, Pomoransky J, Breitbach CJ, Diallo JS, Stojdl DF, Bell JC, Wan Y, Lichty BD.

Oncolytic Virother. 2018 Nov 26;7:117-128. doi: 10.2147/OV.S154494. eCollection 2018. Review.

23.

Necessity of technicians for computerized neuropsychological assessment devices in multiple sclerosis.

Wojcik CM, Rao SM, Schembri AJ, Drake AS, Maruff P, Schindler D, Alberts J, Yasin F, Pol J, Weinstock-Guttman B, Benedict RH.

Mult Scler. 2018 Nov 22:1352458518813287. doi: 10.1177/1352458518813287. [Epub ahead of print]

PMID:
30465463
24.

Gold Standard Assessment of Immunogenic Cell Death in Oncological Mouse Models.

Humeau J, Lévesque S, Kroemer G, Pol JG.

Methods Mol Biol. 2019;1884:297-315. doi: 10.1007/978-1-4939-8885-3_21.

PMID:
30465212
25.

How community pharmacists prioritize cognitive pharmaceutical services.

van de Pol JM, Koster ES, Hövels AM, Bouvy ML.

Res Social Adm Pharm. 2019 Sep;15(9):1088-1094. doi: 10.1016/j.sapharm.2018.09.012. Epub 2018 Sep 26.

26.

Impact of chemotactic factors and receptors on the cancer immune infiltrate: a bioinformatics study revealing homogeneity and heterogeneity among patient cohorts.

Stoll G, Pol J, Soumelis V, Zitvogel L, Kroemer G.

Oncoimmunology. 2018 Aug 6;7(10):e1484980. doi: 10.1080/2162402X.2018.1484980. eCollection 2018.

27.

Heating it up: Oncolytic viruses make tumors 'hot' and suitable for checkpoint blockade immunotherapies.

Gujar S, Pol JG, Kroemer G.

Oncoimmunology. 2018 Mar 13;7(8):e1442169. doi: 10.1080/2162402X.2018.1442169. eCollection 2018.

28.

HDACi Delivery Reprograms Tumor-Infiltrating Myeloid Cells to Eliminate Antigen-Loss Variants.

Nguyen A, Ho L, Workenhe ST, Chen L, Samson J, Walsh SR, Pol J, Bramson JL, Wan Y.

Cell Rep. 2018 Jul 17;24(3):642-654. doi: 10.1016/j.celrep.2018.06.040.

29.

Metabolic vulnerability of cisplatin-resistant cancers.

Obrist F, Michels J, Durand S, Chery A, Pol J, Levesque S, Joseph A, Astesana V, Pietrocola F, Wu GS, Castedo M, Kroemer G.

EMBO J. 2018 Jul 13;37(14). pii: e98597. doi: 10.15252/embj.201798597. Epub 2018 Jun 6.

30.

Dying to Be Noticed: Epigenetic Regulation of Immunogenic Cell Death for Cancer Immunotherapy.

Cruickshank B, Giacomantonio M, Marcato P, McFarland S, Pol J, Gujar S.

Front Immunol. 2018 Apr 3;9:654. doi: 10.3389/fimmu.2018.00654. eCollection 2018. Review.

31.

Anti-CTLA-4 immunotherapy: uncoupling toxicity and efficacy.

Pol J, Kroemer G.

Cell Res. 2018 May;28(5):501-502. doi: 10.1038/s41422-018-0031-9. Epub 2018 Mar 28. No abstract available.

32.

Pharmacy in transition: A work sampling study of community pharmacists using smartphone technology.

van de Pol JM, Geljon JG, Belitser SV, Frederix GWJ, Hövels AM, Bouvy ML.

Res Social Adm Pharm. 2019 Jan;15(1):70-76. doi: 10.1016/j.sapharm.2018.03.004. Epub 2018 Mar 9.

33.

TNF inhibitor treatment is associated with a lower risk of hand osteoarthritis progression in rheumatoid arthritis patients after 10 years.

Loef M, Kroon FPB, Bergstra SA, van der Pol JA, Lems WF, Kerstens PJSM, Allaart CF, Kloppenburg M.

Rheumatology (Oxford). 2018 Nov 1;57(11):1917-1924. doi: 10.1093/rheumatology/key016.

PMID:
29471377
34.

Uncomplicated 90Y Selective Internal Radio Therapy in a Patient With Hepatocellular Carcinoma After Arterial and Portal Vein Embolizations.

van der Pol J, de Vos-Geelen J, Bucerius J, Mitea C, van der Leij C.

Clin Nucl Med. 2018 Mar;43(3):180-182. doi: 10.1097/RLU.0000000000001945.

PMID:
29389772
35.

Teachers' monitoring of students' text comprehension: can students' keywords and summaries improve teachers' judgment accuracy?

Engelen JAA, Camp G, van de Pol J, de Bruin ABH.

Metacogn Learn. 2018;13(3):287-307. doi: 10.1007/s11409-018-9187-4. Epub 2018 Dec 10.

36.

Antitumor Benefits of Antiviral Immunity: An Underappreciated Aspect of Oncolytic Virotherapies.

Gujar S, Pol JG, Kim Y, Lee PW, Kroemer G.

Trends Immunol. 2018 Mar;39(3):209-221. doi: 10.1016/j.it.2017.11.006. Epub 2017 Dec 20. Review.

PMID:
29275092
37.

Trial watch: DNA-based vaccines for oncological indications.

Pierini S, Perales-Linares R, Uribe-Herranz M, Pol JG, Zitvogel L, Kroemer G, Facciabene A, Galluzzi L.

Oncoimmunology. 2017 Nov 20;6(12):e1398878. doi: 10.1080/2162402X.2017.1398878. eCollection 2017. Review.

38.

New Food Baits for Trapping German Cockroaches, Blattella germanica (L.) (Dictyoptera: Blattellidae).

Pol JC, Jimenez SI, Gries G.

J Econ Entomol. 2017 Dec 5;110(6):2518-2526. doi: 10.1093/jee/tox247.

PMID:
29029107
39.

Immunogenic stress and death of cancer cells: Contribution of antigenicity vs adjuvanticity to immunosurveillance.

Bloy N, Garcia P, Laumont CM, Pitt JM, Sistigu A, Stoll G, Yamazaki T, Bonneil E, Buqué A, Humeau J, Drijfhout JW, Meurice G, Walter S, Fritsche J, Weinschenk T, Rammensee HG, Melief C, Thibault P, Perreault C, Pol J, Zitvogel L, Senovilla L, Kroemer G.

Immunol Rev. 2017 Nov;280(1):165-174. doi: 10.1111/imr.12582. Review.

PMID:
29027230
40.

Customized Viral Immunotherapy for HPV-Associated Cancer.

Atherton MJ, Stephenson KB, Pol J, Wang F, Lefebvre C, Stojdl DF, Nikota JK, Dvorkin-Gheva A, Nguyen A, Chen L, Johnson-Obaseki S, Villeneuve PJ, Diallo JS, Dimitroulakos J, Wan Y, Lichty BD.

Cancer Immunol Res. 2017 Oct;5(10):847-859. doi: 10.1158/2326-6066.CIR-17-0102. Epub 2017 Sep 14.

41.

Is optimising gout treatment the key to closing the mortality gap in gout patients?

Ten Brinck RM, de Moel EC, van der Pol JA, van Beest S, de Koning A, Huizinga TWJ.

Ann Rheum Dis. 2018 Jan;77(1):e2. doi: 10.1136/annrheumdis-2017-211638. Epub 2017 May 25. No abstract available.

PMID:
28546256
42.

The impact of demand management strategies on parents' decision-making for out-of-hours primary care: findings from a survey in The Netherlands.

Giesen MJ, Keizer E, van de Pol J, Knoben J, Wensing M, Giesen P.

BMJ Open. 2017 May 9;7(5):e014605. doi: 10.1136/bmjopen-2016-014605. Erratum in: BMJ Open. 2017 Jun 26;7(6):e014605corr1.

43.

Gut Colonization by Methanogenic Archaea Is Associated with Organic Dairy Consumption in Children.

van de Pol JA, van Best N, Mbakwa CA, Thijs C, Savelkoul PH, Arts IC, Hornef MW, Mommers M, Penders J.

Front Microbiol. 2017 Mar 10;8:355. doi: 10.3389/fmicb.2017.00355. eCollection 2017.

44.

Consequences of radiopharmaceutical extravasation and therapeutic interventions: a systematic review.

van der Pol J, Vöö S, Bucerius J, Mottaghy FM.

Eur J Nucl Med Mol Imaging. 2017 Jul;44(7):1234-1243. doi: 10.1007/s00259-017-3675-7. Epub 2017 Mar 16. Review.

45.

Visible-Light Excitation of a Molecular Motor with an Extended Aromatic Core.

van Leeuwen T, Pol J, Roke D, Wezenberg SJ, Feringa BL.

Org Lett. 2017 Mar 17;19(6):1402-1405. doi: 10.1021/acs.orglett.7b00317. Epub 2017 Mar 1.

46.

Crystalline inclusions in myeloma cells: Need to go beyond morphologic curiosity.

Agashe SR, Pol JN, Kadkol GA, Patil PP.

Indian J Pathol Microbiol. 2017 Jan-Mar;60(1):139-140. doi: 10.4103/0377-4929.200036. No abstract available.

47.

Metabolic effects of fasting on human and mouse blood in vivo.

Pietrocola F, Demont Y, Castoldi F, Enot D, Durand S, Semeraro M, Baracco EE, Pol J, Bravo-San Pedro JM, Bordenave C, Levesque S, Humeau J, Chery A, Métivier D, Madeo F, Maiuri MC, Kroemer G.

Autophagy. 2017 Mar 4;13(3):567-578. doi: 10.1080/15548627.2016.1271513. Epub 2017 Jan 6.

48.

Positive vs. Negative: The Impact of Question Polarity in Voting Advice Applications.

Holleman B, Kamoen N, Krouwel A, Pol JV, Vreese C.

PLoS One. 2016 Oct 10;11(10):e0164184. doi: 10.1371/journal.pone.0164184. eCollection 2016.

49.

Fasting improves anticancer immunosurveillance via autophagy induction in malignant cells.

Pietrocola F, Pol J, Kroemer G.

Cell Cycle. 2016 Dec 16;15(24):3327-3328. doi: 10.1080/15384101.2016.1224797. Epub 2016 Sep 2. No abstract available.

50.

Autophagy induction for the treatment of cancer.

Pietrocola F, Pol J, Vacchelli E, Baracco EE, Levesque S, Castoldi F, Maiuri MC, Madeo F, Kroemer G.

Autophagy. 2016 Oct 2;12(10):1962-1964. Epub 2016 Aug 17.

Supplemental Content

Support Center